Ototoxicity
Definition: Damage to the inner ear caused by drugs/chemicals leading to sensorineural hearing loss (SNHL), tinnitus, and sometimes vertigo.
1. Aminoglycoside Antibiotics
Mechanism: Binds to ribosome → interferes with protein synthesis → death of cochlear cells.
| Type | Drugs | Target Site |
|---|---|---|
| Vestibulotoxic | Streptomycin, Gentamicin, Tobramycin. | Type I Hair Cells (Crista Ampullaris). |
| Cochleotoxic | Neomycin, Kanamycin, Amikacin, Sisomycin, Dihydrostreptomycin. | Outer Hair Cells (Basal coil → Apex). |
High Risk Patients:
- Impaired renal function.
- Elderly (> 65 years).
- Concomitant ototoxic drugs.
- High serum levels / Large doses.
- Genetic susceptibility.
2. Diuretics (Loop Diuretics)
- Drugs: Furosemide, Bumetanide, Ethacrynic acid.
- Mechanism: Blocks Na+/Cl- transport in Loop of Henle → Oedema/Cystic changes in Stria Vascularis.
- Effect: Usually Reversible. (Permanent if renal failure present).
3. Salicylates (Aspirin) & NSAIDs
- Symptoms: Tinnitus, Bilateral SNHL (High frequencies).
- Mechanism: Enzymatic interference (No morphological hair cell damage seen).
- Effect: Reversible upon discontinuation.
- Other NSAIDs: Naproxen, Piroxicam, Ketorolac.
4. Quinine & Chloroquine
Effect: Vasoconstriction in small vessels of cochlea/stria vascularis.
- Usually reversible (Higher doses → Permanent).
- Teratogenic: Congenital deafness/hypoplasia if mother takes in 1st trimester.
5. Cytotoxic Drugs
- Drugs: Nitrogen mustard, Cisplatin, Carboplatin.
- Damage: Outer hair cells of cochlea (Permanent).
6. Deferoxamine
- Use: Iron-chelating agent (Thalassaemia).
- Effect: High-frequency SNHL (Sudden or Delayed).
- Reversibility: Permanent (sometimes reversible).
- Toxicity is to nerves; children affected more.
7. Topical Ear Drops
Absorption occurs through Oval and Round windows if TM is perforated.
Culprits:
- Aminoglycosides: Neomycin, Framycetin, Gentamicin drops.
- Antiseptics: Chlorhexidine (Surgical prep).
- Others: Polymyxin B, Propylene glycol, Antifungals.
📚 Source: ENT Dhingra | Chapter 5
💬 Comments
No comments:
Post a Comment